Save time and get answers to complex questions with AI chat
Complera manufacturer?When will generic fiasap insulin be available?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Are there income restrictions for lipitor's patient program?Patent expiration eu dabrafenib?
See the DrugPatentWatch profile for Omidria
Omidria (phenylephrine and ketorolac injection) received FDA approval on April 10, 2014. [1]
Omidria is used to help improve outcomes in cataract surgery—specifically to reduce the incidence of postoperative ocular pain and constriction (pupillary constriction) during and after cataract procedures. [1]
The FDA’s approval date is listed in the drug’s FDA review/approval history on the FDA label information page for Omidria. [1]
Other Questions About Omidria :